Back to search
FDAFDA · Food and drugs·Recall number D-183-2013

0.9% Sodium Chloride Injection USP, 100 mL Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7984-23,

Published March 13, 2013 · Recall initiated: January 8, 2013

Summary

FDA records drug Class II recall D-183-2013, published March 13, 2013 and initiated January 8, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 325,056 bags; Lot: Lot Number 02-117-JT Exp. 02/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: There is the potential for solution to leak from the administrative port to the fill tube seal.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot Number 02-117-JT Exp. 02/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.9% Sodium Chloride Injection USP, 100 mL Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7984-23, recalled?

Yes. FDA published recall D-183-2013 on March 13, 2013. Reported hazard: Lack of Assurance of Sterility: There is the potential for solution to leak from the administrative port to the fill tube seal.

What should I do if I have this product?

Voluntary: Firm initiated · Letter